These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 11810125)
1. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125 [TBL] [Abstract][Full Text] [Related]
2. Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates. Skvorak K; Liu J; Kruse N; Mehmood R; Das S; Jenne S; Chng C; Lao UL; Duan D; Asfaha J; Du F; Teadt L; Sero A; Ching C; Riggins J; Pope L; Yan P; Mashiana H; Ismaili MHA; McCluskie K; Huisman G; Silverman AP J Inherit Metab Dis; 2023 Nov; 46(6):1089-1103. PubMed ID: 37494004 [TBL] [Abstract][Full Text] [Related]
4. The interplay of psychosis and non-compliance with fatal outcome in an adult with MSUD. Falah N; Pendyal S; Sasannejad C; Gibson A; Lee YL; McDonald M; Koeberl D Am J Med Genet A; 2024 Sep; 194(9):e63637. PubMed ID: 38682838 [TBL] [Abstract][Full Text] [Related]
5. The oral phenotype and dental management in patients with maple syrup urine disease; case report and scoping review. Hassona Y; Alqaisi D; Flaifl Y; Alkilani A BMC Oral Health; 2024 Mar; 24(1):362. PubMed ID: 38515181 [TBL] [Abstract][Full Text] [Related]
6. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Frazier DM; Allgeier C; Homer C; Marriage BJ; Ogata B; Rohr F; Splett PL; Stembridge A; Singh RH Mol Genet Metab; 2014 Jul; 112(3):210-7. PubMed ID: 24881969 [TBL] [Abstract][Full Text] [Related]
7. Utility of hemodialysis in maple syrup urine disease. Puliyanda DP; Harmon WE; Peterschmitt MJ; Irons M; Somers MJ Pediatr Nephrol; 2002 Apr; 17(4):239-42. PubMed ID: 11956873 [TBL] [Abstract][Full Text] [Related]
8. Haemodialysis is an effective treatment in acute metabolic decompensation of maple syrup urine disease. Atwal PS; Macmurdo C; Grimm PC Mol Genet Metab Rep; 2015 Sep; 4():46-8. PubMed ID: 26937409 [TBL] [Abstract][Full Text] [Related]
9. Duration of extracorporeal therapy in acute maple syrup urine disease: a kinetic model. Phan V; Clermont MJ; Merouani A; Litalien C; Tucci M; Lambert M; Mitchell G; Jouvet P Pediatr Nephrol; 2006 May; 21(5):698-704. PubMed ID: 16518628 [TBL] [Abstract][Full Text] [Related]
10. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration. Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568 [TBL] [Abstract][Full Text] [Related]
11. [Peritoneal dialysis in a neonate with maple syrup urine disease. A case report]. Ramírez F; Mato I; Barboza A; Cejas Bestard N Arch Argent Pediatr; 2020 Apr; 118(2):e178-e182. PubMed ID: 32199060 [TBL] [Abstract][Full Text] [Related]
12. Continuous Venovenous Hemodiafiltration in the Treatment of Maple Syrup Urine Disease. Demirkol D; Şık G; Topal N; Çıtak A; Zeybek Ç; Tüten A; Bilge I Blood Purif; 2016; 42(1):27-32. PubMed ID: 26998605 [TBL] [Abstract][Full Text] [Related]
14. Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease. Sánchez-Pintos P; Meavilla S; López-Ramos MG; García-Cazorla Á; Couce ML Front Pediatr; 2022; 10():969741. PubMed ID: 36046474 [TBL] [Abstract][Full Text] [Related]
15. Real-world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid-free formulas in France and Germany: A retrospective observational study. de Lonlay P; Posset R; Mütze U; Mention K; Lamireau D; Schiff M; Servais A; Arnoux JB; Brassier A; Dao M; Douillard C; Ottolenghi C; Pontoizeau C; Miotto F; Le Mouhaër J JIMD Rep; 2021 May; 59(1):110-119. PubMed ID: 33977036 [TBL] [Abstract][Full Text] [Related]
16. Continuous renal replacement therapy in neonates weighing less than 3 kg. Sohn YB; Paik KH; Cho HY; Kim SJ; Park SW; Kim ES; Chang YS; Park WS; Choi YH; Jin DK Korean J Pediatr; 2012 Aug; 55(8):286-92. PubMed ID: 22977441 [TBL] [Abstract][Full Text] [Related]
17. Controversies in paediatric continuous renal replacement therapy. Maclaren G; Butt W Intensive Care Med; 2009 Apr; 35(4):596-602. PubMed ID: 19183942 [TBL] [Abstract][Full Text] [Related]
19. Impact of inborn errors of metabolism on admission and mortality in a pediatric intensive care unit. Jouvet P; Touati G; Lesage F; Dupic L; Tucci M; Saudubray JM; Hubert P Eur J Pediatr; 2007 May; 166(5):461-5. PubMed ID: 16941128 [TBL] [Abstract][Full Text] [Related]